“ Whatever new term we hear is likely to induce a cringe at first. Most had a hard time with Leronlimab when they made the switch from Pro-140.”
I always disliked Vyrologix. Glad we still talk about Leronlimab. Perhaps that dates me.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-